UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications

Expert opinion on investigational drugs, 2023-12, Vol.32 (12), p.1095-1103

2023

Link zum Volltext

Verfügbarkeit prüfen

Markers of inflammation and CD8 T‐cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV‐infected individuals

HIV medicine, 2013-07, Vol.14 (6), p.385-390

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV-Infected Subjects: A Randomized, Controlled Study

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1290-1296

2008

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda

HIV medicine, 2020-02, Vol.21 (2), p.119-127

2020

Link zum Volltext

Verfügbarkeit prüfen

Markers of renal disease and function are associated with systemic inflammation in HIV infection

HIV medicine, 2015-11, Vol.16 (10), p.591-598

2015

Link zum Volltext

Verfügbarkeit prüfen

Alcohol and dietary factors associate with gut integrity and inflammation in HIV‐infected adults

HIV medicine, 2017-07, Vol.18 (6), p.402-411

2017

Link zum Volltext

Verfügbarkeit prüfen

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial

HIV medicine, 2014-08, Vol.15 (7), p.431-441

2014

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D, osteoprotegerin/receptor activator of nuclear factor‐kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV‐infected patients with reduced bone mineral density

HIV medicine, 2016-03, Vol.17 (3), p.196-205

2016

Link zum Volltext

Verfügbarkeit prüfen

Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV‐infected adults on stable antiretroviral therapy

HIV medicine, 2012-11, Vol.13 (10), p.609-616

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress

HIV medicine, 2012-02, Vol.13 (2), p.98-106

2012

Link zum Volltext

Verfügbarkeit prüfen

Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices

European journal of clinical nutrition, 2008-08, Vol.62 (8), p.1031-1037

2008

Link zum Volltext

Verfügbarkeit prüfen

Metabolic complications of HIV therapy in children

AIDS (London), 2004-09, Vol.18 (13), p.1753-1768

2004

Link zum Volltext

Verfügbarkeit prüfen

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

Annals of internal medicine, 2014-10, Vol.161 (7), p.I

2014

Link zum Volltext

Verfügbarkeit prüfen

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

AIDS (London), 2005-01, Vol.19 (1), p.15-23

2005

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein‐associated phospholipase A2 and cardiovascular disease risk in HIV infection

HIV medicine, 2014-10, Vol.15 (9), p.537-546

2014

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration

AIDS (London), 2013-04, Vol.27 (7), p.1071-1080

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2014-04, Vol.209 (8), p.1156-1164

2014

Link zum Volltext

Verfügbarkeit prüfen

Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

Clinical infectious diseases, 2014-02, Vol.58 (4), p.588-595

2014

Link zum Volltext

Verfügbarkeit prüfen

Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Value in health, 2015-11, Vol.18 (7), p.A590-A590

2015

Link zum Volltext

Verfügbarkeit prüfen

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D

Antiviral therapy, 2010, Vol.15 (3), p.425-429

2010

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy

Clinical infectious diseases, 2009-10, Vol.49 (7), p.1119-1127

2009

Link zum Volltext

Verfügbarkeit prüfen

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen

Journal of acquired immune deficiency syndromes (1999), 2009-08, Vol.51 (5), p.554

2009

Link zum Volltext

Verfügbarkeit prüfen

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1483-1488

2013

Link zum Volltext

Verfügbarkeit prüfen

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

Clinical infectious diseases, 2011-07, Vol.53 (2), p.185-196

2011

Link zum Volltext

Verfügbarkeit prüfen

Higher subclinical cardiac fibrosis in South African youth with HIV: results from the CTAAC-heart study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(117)

Sprache

Englisch
(117)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(90)
Humans
(87)
Infectious Diseases
(73)
Female
(63)
Male
(59)
Adult
(58)
Biological And Medical Sciences
(54)
Hiv Infections - Drug Therapy
(54)
Medical Sciences
(54)
Immunology
(51)
Human Immunodeficiency Virus
(46)
Viral Diseases
(46)
Human Viral Diseases
(45)
Middle Aged
(45)
Hiv
(44)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(42)
Virology
(36)
Pharmacology. Drug Treatments
(32)
Aids/hiv
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications

Markers of inflammation and CD8 T‐cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV‐infected individuals

Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV-Infected Subjects: A Randomized, Controlled Study

Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda

Markers of renal disease and function are associated with systemic inflammation in HIV infection

Alcohol and dietary factors associate with gut integrity and inflammation in HIV‐infected adults

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial

Vitamin D, osteoprotegerin/receptor activator of nuclear factor‐kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV‐infected patients with reduced bone mineral density

Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV‐infected adults on stable antiretroviral therapy

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress

Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices

Metabolic complications of HIV therapy in children

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

Lipoprotein‐associated phospholipase A2 and cardiovascular disease risk in HIV infection

Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

Higher subclinical cardiac fibrosis in South African youth with HIV: results from the CTAAC-heart study

Suchergebnisse filtern